12:00 AM
 | 
Jan 06, 2014
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Tekmira preclinical data

In non-human primates, once-daily 0.5 mg/kg TKM-Ebola for 7 days led to an 83% survival rate when treatment was initiated 24-48 hours after infection with the Zaire variant of Ebola virus and a 67% survival rate when treatment was initiated 72 hours after infection. No animals...

Read the full 207 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >